Akkermansia muciniphila is a naturally occurring bacterium that lives mainly in the mucus layer of the human large intestine. Unlike many familiar probiotic bacteria, it is especially adapted to use mucin — a major component of intestinal mucus — as a source of nutrients.
This article is part of the AKK Knowledge Centre, our guide hub for Akkermansia, gut health and microbiome research.
For related context, see what Akkermansia does in the gut.
Since it was first isolated from a human intestinal sample in 2004, Akkermansia muciniphila has become one of the most widely discussed bacteria in modern gut microbiome research. Scientists are particularly interested in its relationship with the intestinal mucus environment, gut barrier function, microbial ecology and metabolic health.
However, interest in Akkermansia should not be confused with proof that “more is always better” or that taking an Akkermansia supplement will automatically produce a particular health outcome. Human research is growing, but many questions remain open.
Key Takeaways
- Akkermansia muciniphila is a naturally occurring member of the human gut microbiome.
- It is most closely associated with the mucus layer of the large intestine.
- Its ability to use mucin makes it biologically different from many traditional probiotic bacteria.
- Akkermansia has become an important research topic in gut barrier and metabolic health.
- Both live and pasteurised forms of Akkermansia have been studied.
- Human clinical research is increasing, but results from individual studies cannot automatically be applied to every Akkermansia product.
- Akkermansia abundance varies considerably between individuals, so a higher level should not automatically be interpreted as “healthier.”
What Exactly Is Akkermansia muciniphila?
Akkermansia muciniphila is an anaerobic bacterium, meaning it is adapted to environments with very little oxygen.
It was first isolated and formally described in 2004 by researchers studying bacteria capable of using intestinal mucin as a nutrient source. The original strain, known as MucT, was obtained from a human faecal sample and identified as a previously unknown bacterial genus and species.
One characteristic makes Akkermansia particularly interesting:
it specialises in interacting with mucin.
Mucin is a family of large glycoproteins that forms an important part of the mucus covering the intestinal surface.
Rather than simply floating in the contents of the intestine, Akkermansia occupies an ecological niche close to this mucus environment. That puts it at an interesting interface between:
- the intestinal contents,
- the gut microbiome,
- the mucus layer,
- and the cells lining the intestine.
This location is one reason researchers have become so interested in the organism.
Where Does Akkermansia Live in the Gut?
Akkermansia is primarily associated with the mucus layer of the large intestine, or colon.
The intestinal wall is not directly exposed to everything moving through the digestive tract. A mucus layer helps create a physical and biological interface between intestinal contents and the epithelial cells lining the gut.
Akkermansia is particularly well adapted to this environment because it possesses numerous enzymes capable of breaking down components of mucin.
A simplified view looks like this:
Intestinal contents ↓ Outer mucus environment ↓ Akkermansia and other mucus-associated microbes ↓ Inner mucus layer ↓ Intestinal epithelial cells
Akkermansia is a common member of the adult intestinal microbiome, but its abundance varies greatly between people and between studies.
Some earlier studies estimated that it may represent around 1–3% of faecal bacteria in many healthy adults. More recent microbiome datasets also demonstrate substantial differences in detection and abundance depending on the population and analytical method used.
For this reason, there is no single Akkermansia percentage that should automatically be considered “ideal.”
Why Does Akkermansia Feed on Mucin?
The word muciniphila reflects one of the bacterium's defining characteristics: its strong relationship with mucin.
Mucin contains carbohydrates and proteins that certain specialised bacteria can use as nutrients.
Akkermansia contains a large collection of enzymes that allows it to break down different components of mucin.
But this relationship is more complicated than simply saying:
“Akkermansia eats the gut lining.”
That description is misleading.
The intestinal mucus layer is a dynamic biological environment that is continuously produced and renewed. As Akkermansia processes mucin, it also produces metabolites that may become available to other members of the gut microbiome.
This creates opportunities for cross-feeding, where the metabolic activity of one microorganism supports the activity of others.
Modern research therefore increasingly looks at Akkermansia as part of a microbial ecosystem rather than as an isolated “good bacterium.”
Why Are Scientists So Interested in Akkermansia?
Akkermansia attracted attention because observational studies repeatedly found relationships between its abundance and different aspects of human health.
Researchers have subsequently studied Akkermansia in relation to areas including:
- the intestinal mucus environment,
- gut barrier biology,
- microbiome interactions,
- immune signalling,
- metabolic health,
- body-weight regulation,
- glucose and lipid metabolism.
Importantly, an association does not prove causation.
Finding lower Akkermansia abundance in one group of people does not demonstrate that low Akkermansia caused their condition.
Likewise, increasing Akkermansia does not automatically mean that a person will experience a health benefit.
For many years, much of the enthusiasm surrounding Akkermansia came from animal and laboratory research. Human intervention studies are now expanding, but the evidence base remains much smaller than the headlines surrounding this bacterium might suggest.
What Have Human Studies Found?
One of the first important human intervention studies was published in Nature Medicine in 2019.
Researchers enrolled 40 adults with overweight or obesity and insulin resistance, with 32 completing the study. Participants received either live Akkermansia, pasteurised Akkermansia or placebo daily for three months.
The study was primarily designed as a proof-of-concept investigation of safety, tolerability and metabolic outcomes. Both live and pasteurised preparations were reported as well tolerated during the study, while several metabolic measurements changed in the pasteurised Akkermansia group.
Because this was a relatively small exploratory study, it should not be interpreted as proof that all Akkermansia supplements produce the same effects.
In 2026, another randomised controlled study published in Nature Medicine examined 90 adults with overweight or obesity. After an initial weight-loss phase, participants entered a 24-week weight-maintenance period and received either pasteurised A. muciniphila MucT or placebo.
Participants receiving the specific pasteurised preparation experienced less weight regain on average than the placebo group during the study period.
But several limitations still matter:
- the study involved a specific pasteurised strain and preparation,
- participants belonged to a specific population,
- supplementation followed a structured weight-loss intervention,
- the study does not establish that every commercial Akkermansia product is equivalent,
- and longer-term research remains valuable.
The correct conclusion is therefore not:
“Akkermansia has been proven to cause weight loss.”
A more accurate interpretation is:
Human clinical research is beginning to provide evidence that specific Akkermansia preparations may influence certain metabolic outcomes under defined study conditions. More research is needed to understand who may benefit, which preparations matter and how results translate into everyday use.
Is Akkermansia a Probiotic?
This question is more complicated than it first appears.
Most consumers associate probiotics with familiar bacteria such as Lactobacillus and Bifidobacterium species.
Akkermansia is biologically different. It lives in a different ecological niche and specialises in interaction with intestinal mucin.
For this reason, it is frequently described in scientific literature as a potential “next-generation probiotic.”
But “next-generation” does not mean stronger, better than every traditional probiotic, or more effective for everyone.
There is another complication: some Akkermansia products use pasteurised, non-living bacteria. A classical definition of a probiotic usually refers to live microorganisms. Therefore, the terminology used for different Akkermansia preparations needs to be considered carefully.
What Is Pasteurised Akkermansia?
Pasteurised Akkermansia has been exposed to controlled heat treatment so that the bacterial cells are no longer viable.
Preclinical research found that certain structural components of Akkermansia remain biologically interesting after pasteurisation. One extensively studied example is an outer-membrane protein known as Amuc_1100.
This contributed to interest in pasteurised Akkermansia and eventually to human studies.
Live and pasteurised Akkermansia should therefore not be treated as interchangeable terms.
Is More Akkermansia Always Better?
No.
Gut health cannot be reduced to:
More Akkermansia = better gut health.
The human microbiome is an ecosystem containing hundreds of microbial species interacting with diet, genetics, medications, age, physical activity, sleep, environment and each other.
A person should not assume they are unhealthy simply because a commercial microbiome test reports a low Akkermansia level.
Likewise, a high result does not guarantee good health.
Can Diet Influence Akkermansia?
Probably — but there is no single “Akkermansia food.”
Researchers have investigated relationships between Akkermansia and dietary fibre, prebiotics, polyphenol-rich foods, plant diversity and overall dietary patterns.
However, responses vary between individuals.
It is more useful to think about creating a diverse, fibre-containing dietary environment than searching for one miracle food that supposedly “boosts Akkermansia.”
What Current Research Does Not Prove
Current evidence does not mean that:
- everyone needs an Akkermansia supplement,
- low Akkermansia means a person has a disease,
- higher Akkermansia is always better,
- Akkermansia alone determines body weight,
- Akkermansia replaces a healthy diet,
- all Akkermansia supplements are equivalent,
- animal-study findings automatically apply to humans,
- research on one strain or preparation applies to every commercial product.
What Should You Look for in an Akkermansia Supplement?
1. What form of Akkermansia is being used?
Is it live, pasteurised, another non-viable preparation, or a formula designed to support the existing gut environment?
2. Is the amount clearly stated?
Look for a clear daily serving rather than an impressive number without context.
3. Is the formulation explained?
Consumers should be able to understand why supporting ingredients are present.
4. Are storage instructions clear?
Always follow the specific product label.
5. Are the claims realistic?
Be cautious of claims such as “guaranteed weight loss,” “repairs your gut,” “reverses metabolic disease,” or “clinically proven fat-burning bacteria.”
Frequently Asked Questions
Is Akkermansia naturally found in the human body?
Yes. Akkermansia is a naturally occurring member of the intestinal microbiome and is commonly detected in human gut samples.
Where in the intestine is Akkermansia found?
It is most closely associated with the mucus environment of the large intestine, particularly the colon.
Is Akkermansia the same as Lactobacillus?
No. They belong to different bacterial groups and occupy different ecological niches.
Is Akkermansia a “good bacterium”?
Calling a bacterium simply “good” or “bad” is an oversimplification.
Can I increase Akkermansia naturally?
Diet and lifestyle may influence Akkermansia abundance as part of broader changes in the microbiome.
Does Akkermansia help with weight management?
Some human studies involving specific Akkermansia preparations and defined populations have reported effects on metabolic or weight-related outcomes. That does not mean Akkermansia alone causes weight loss.
Are live and pasteurised Akkermansia the same?
No. Live Akkermansia contains viable bacterial cells, while pasteurised Akkermansia has undergone heat treatment and is no longer viable.
The Bottom Line
Akkermansia muciniphila is one of the most interesting members of the human gut microbiome currently being studied.
Its unusual relationship with the intestinal mucus layer gives it a biological role quite different from many familiar probiotic bacteria.
The most useful way to understand Akkermansia is not as a “miracle bacterium,” but as one member of a complex intestinal ecosystem.
Continue Learning
Selected Scientific References
- Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International Journal of Systematic and Evolutionary Microbiology. 2004.
- Geerlings SY, Kostopoulos I, de Vos WM, Belzer C. Akkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How? Microorganisms. 2018.
- Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine. 2019.
- Plovier H, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine. 2017.
- Mount S, Canfora EE, Jocken JW, et al. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial. Nature Medicine. 2026.
Educational Disclaimer
This article is provided for general educational purposes. It is not intended to diagnose, treat, cure or prevent any disease and should not replace advice from a qualified healthcare professional.